Option and Evaluation Deals in Pharmaceuticals and Biotechnology provides a detailed understanding and analysis of how and why companies enter option and evaluation deals.
Fully revised and updated, the report provides details of option and evaluation deals from 2016 to 2023.
The report provides access to option and evaluation deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.
Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.
This report contains a comprehensive listing of option and evaluation deals announced since 2016 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual option and evaluation contract documents as submitted to the Securities Exchange Commission by companies and their partners.
The initial chapters of this report provide an orientation of option and evaluation dealmaking and business activities.
Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview and analysis of the trends in option and evaluation as well as a discussion on the merits of the type of deal.
Chapter 3 provides an overview of the structure of option and evaluation deals.
Chapter 4 provides a review of the leading option and evaluation deals since 2016. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.
Chapter 5 provides a comprehensive listing of the top 25 most active option and evaluation dealmaker companies. Each deal title links via Current Agreements deals and alliances database to an online version of the full deal record, and where available, the actual contract document, providing easy access to each deal record on demand.
Chapter 6 provides a comprehensive and detailed review of option and evaluation deals organized by company A-Z, therapy, technology and industry type signed and announced since 2016 where a contract document is available. Contract documents provide an indepth insight into the actual deal terms agreed between the parties with respect to the option and evaluation deal.
The deal directory includes a comprehensive listing of all option and evaluation deals announced since 2016. Each listing is organized as a deal directory by company A-Z, therapeutic area and technology type. Each deal title links via hyperlink to an online version of the deal record including, where available, the actual contract document.
The report also includes numerous table and figures that illustrate the trends and activities in option and evaluation dealmaking since 2016.
In conclusion, this report provides everything a prospective dealmaker needs to know about option and evaluation alliances.
Option and Evaluation Deals in Pharmaceuticals and Biotechnology provides comprehensive access to available records for option and evaluation deals, including contract documents where available.
Fully revised and updated, the report provides details of option and evaluation deals from 2016 to 2023.
The report provides access to option and evaluation deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.
Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.
This report contains a comprehensive listing of option and evaluation deals announced since 2016 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual option and evaluation contract documents as submitted to the Securities Exchange Commission by companies and their partners.
The initial chapters of this report provide an orientation of option and evaluation dealmaking and business activities.
Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview and analysis of the trends in option and evaluation as well as a discussion on the merits of the type of deal.
Chapter 3 provides an overview of the structure of option and evaluation deals.
Chapter 4 provides a review of the leading option and evaluation deals since 2016. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.
Chapter 5 provides a comprehensive listing of the top 25 most active option and evaluation dealmaker companies. Each deal title links via Current Agreements deals and alliances database to an online version of the full deal record, and where available, the actual contract document, providing easy access to each deal record on demand.
Chapter 6 provides a comprehensive and detailed review of option and evaluation deals organized by company A-Z, therapy, technology and industry type signed and announced since 2016 where a contract document is available. Contract documents provide an indepth insight into the actual deal terms agreed between the parties with respect to the option and evaluation deal.
The deal directory includes a comprehensive listing of all option and evaluation deals announced since 2016. Each listing is organized as a deal directory by company A-Z, therapeutic area and technology type. Each deal title links via hyperlink to an online version of the deal record including, where available, the actual contract document.
The report also includes numerous table and figures that illustrate the trends and activities in option and evaluation dealmaking since 2016.
In conclusion, this report provides everything a prospective dealmaker needs to know about option and evaluation alliances.
Key benefits
Option and Evaluation Deals in Pharmaceuticals and Biotechnology provides the reader with the following key benefits:
- Understand deal trends since 2016
- Browse option and evaluation deals
- Benchmark analysis - identify market value of transactions
- Financials terms
- Directory of deals by company A-Z, therapy focus and technology type
- Leading deals by value
- Most active dealmakers
- Identify assets and deal terms for each transaction
- Access contract documents - insights into deal structures
- Due diligence - assess suitability of your proposed deal terms for partner companies
- Save hundreds of hours of research time
Report scope
Option and Evaluation Deals in Pharmaceuticals and Biotechnology is intended to provide the reader with an in-depth understanding of the option and evaluation trends and structure of deals entered into by leading biopharma companies worldwide.Option and Evaluation Deals in Pharmaceuticals and Biotechnology includes:
- Trends in option and evaluation dealmaking in the biopharma industry
- Overview of option and evaluation deal structure
- Directory of option and evaluation deal records covering pharmaceutical and biotechnology
- The leading option and evaluation deals by value
- Most active option and evaluation dealmakers
- The leading option and evaluation partnering resources
In Option and Evaluation Deals in Pharmaceuticals and Biotechnology, the available deals are listed by:
- Company A-Z
- Headline value
- Therapeutic area
- Technology type
Option and Evaluation Deals in Pharmaceuticals and Biotechnology provides comprehensive access to available records for option and evaluation deals, including contract documents where available.
Analyzing contract agreements allows due diligence of:
- What are the rights granted or optioned?
- What rights are granted by the agreement?
- What exclusivity is granted?
- What is the payment structure for the deal?
- How are sales and payments audited?
- What is the deal term?
- How are the key terms of the agreement defined?
- How are intellectual property rights handled and owned?
- Who is responsible for commercialization?
- Who is responsible for development, supply, and manufacture?
- How is confidentiality and publication managed?
- How are disputes resolved?
- Under what conditions can the deal be terminated?
- What happens when there is a change of ownership?
- What sublicensing and subcontracting provisions have been agreed?
- Which boilerplate clauses does the company insist upon?
- Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
- Which jurisdiction does the company insist upon for agreement law?
Table of Contents
Executive SummaryChapter 1 - Introduction
Chapter 2 - Trends in option and evaluation dealmaking
Chapter 3 - Overview of option and evaluation deal structure
Chapter 4 - Leading option and evaluation deals
Chapter 5 - Top 25 most active option and evaluation dealmakers
Chapter 6 - option and evaluation deals including contracts directory
Deal directory
TABLE OF FIGURES
Companies Mentioned
A selection of companies mentioned in this report includes:
- 3D Medicines
- 3SBio
- 4D Molecular Therapeutics
- 4D Pharma
- A2A Pharmaceuticals
- AADi
- Abbott Laboratories
- Abbvie
- AbClon
- Abide Therapeutics
- Abingworth Management
- Ablynx
- Abyrx
- Achaogen
- AC Immune
- Acucela
- Adagene
- Adapsyn Bioscience
- Adaptimmune
- Adaptive Biotechnologies
- Adare Pharmaceuticals
- ADC Therapeutics
- Addex Therapeutics
- Adimab
- AdoRx Therapeutics
- ADT Pharmaceuticals
- Aduro BioTech
- Advaite
- Advanced Accelerator Applications
- Advanced Cardiac Therapeutics
- Advanced Proteome Therapeutics
- Advaxis
- Aegis Therapeutics
- Aerie Pharmaceuticals
- AEterna Zentaris
- Aevi Genomic Medicine
- Affectis Pharmaceuticals
- Affibody
- Agensys
- Agenus Bio
- AgeX Therapeutics
- Agios Pharmaceuticals
- AgonOx
- AIMM Therapeutics
- AIT Therapeutics
- Akcea Therapeutics
- Akero Therapeutics
- Akkadeas Pharma
- Albumedix
- Alcyone Lifesciences
- Aldeyra Therapeutics
- Alector
- Alexion Pharmaceuticals
- Alfasigma
- AlivaMab Discovery Services
- Alivio Therapeutics
- Allergan
- Alligator Bioscience
- Allogene Therapeutics
- Almirall
- Alnylam Pharmaceuticals
- ALRISE Biosystems
- ALS Association
- Altavant Sciences
- Alteogen
- Alternavida
- Altos Group
- Alverno Clinical Laboratories
- AM-Pharma
- Amag Pharmaceuticals
- Amarantus BioSciences
- Amarillo Biosciences
- Ambys Medicines
- Amgen
- AmorChem
- Amorsa Therapeutics
- Amunix
- Amyris
- Anacor Pharmaceuticals
- Anaeropharma
- Anatara Lifesciences
- Anchiano Therapeutics
- Anergis
- AnGes MG
- Angiodynamics
- Angionetics
- Anokion
- Apceth
- Apeiron Biologics
- Apexigen
- Applied DNA Sciences
- Apricity Health
- Apricus Biosciences
- Aptose Biosciences
- APT Therapeutics
- Aqilion
- Arch Biopartners
- Arcturus Therapeutics
- Arcus Biosciences
- Arcutis Biotherapeutics
- Ardelyx
- arGEN-X
- argenx
- Ariad Pharmaceuticals
- Aridis Pharmaceuticals
- ArQule
- Arrowhead Pharmaceuticals
- Arrow Pharmaceuticals
- Artelo Biosciences
- Arthrex
- Arvinas
- Asahi Kasei
- Ascenion
- Ascentage Pharma
- ASKA Pharmaceuticals
- Aslan Pharma
- Astellas Pharma
- Asterias Biotherapeutics
- Astex Pharmaceuticals
- AstraZeneca
- Atara Biotherapeutics
- Athersys
- Atlab Pharma
- Atomwise
- Atreca
- Audion Therapeutics
- Aurigene Discovery Technologies
- Aurinia Pharmaceuticals
- Auris Medical
- Aurora Cannabis
- Autifony Therapeutics
- Auxogyn
- Avacta
- Avalanche Biotechnologies
- AVEO Oncology
- Avista Pharma Solutions
- Avita Medical
- Basilea Pharmaceutica
- Bassett Salon Solutions
- Bavarian Nordic
- Baxalta
- Baxter International
- Bayer
- Bayer Healthcare
- Beacon Discovery
- Beam Therapeutics
- BeiGene
- Bellicum Pharmaceuticals
- Beta Therapeutics
- Bicycle Therapeutics
- Bill and Melinda Gates Foundation
- Bio-Path
- Bio-Techne
- BioArctic Neuroscience
- BioAtla
- Biocept
- BioCorRx
- Biodel
- BioDuro
- Biogen
- Biohaven Pharmaceutical Holding
- Bioject Medical Technologies
- BiolineRX
- Biomecite Diagnostics
- BioMotiv
- Bioniz Therapeutics
- BioNTech
- Bioprocess Capital Ventures
- BioRap Technologies
- BioSense Global
- BioSig Technologies
- Biotest
- Biothera
- BioTheranostics
- Biotheus
- Bioverativ
- BlinkBio
- Bloom Science
- Bluebird Bio
- Blueprint Medicines
- Boehringer Ingelheim
- Bone Biologics
- BoneSupport
- Boragen
- Boston Scientific
- Boston Therapeutics
- Boston University School of Medicine
- Braeburn Pharmaceuticals
- Brammer Bio
- Breakthrough Diagnostics
- Brigham and Women's Hospital
- Brii Biosciences
- BRIM Biotechnology
- Bristol-Myers Squibb
- Broad Institute
- Bruker
- Buck Institute for Age Research
- C4 Therapeutics
- Caelum Biosciences
- Calico
- California Institute for Biomedical Research
- California Institute for Quantitative Biosciences (QB3)
- Calithera Biosciences
- Calyxt
- Camarus
- Canadian Brain Tumour Consortium
- Canbex Therapeutics
- Cancer Genetics
- Cancer Prevention Pharmaceuticals
- Cancer Research Institute
- Cancer Research Technology
- Cancer Research UK
- Canigma
- Cannassure Therapeutics
- Capricor Therapeutics
- Cardiff University
- Cardinal Partners
- Caribou Biosciences
- Carisma Therapeutics
- Catalent
- CBD Solutions
- Cedars-Sinai Medical Center
- Celgene
- Celimmune
- Celladon
- Celldex Therapeutics
- Cellectar Biosciences
- Cellect Biotechnology
- Cellectis
- Cell Medica
- Cellmid
- Celltech
- Cell Therapy Catapult
- Celltrion
- Celularity
- Celyad
- Censa Pharmaceuticals
- Centers for Disease Control and Prevention
- Centre for Imaging Technology Commercialization
- Centre For The Commercialization Of Antibodies And Biologics
- Cephea Valve Technologies
- Cerulean Pharma
- Cesca Therapeutics
- Charcot-Marie-Tooth Association
- Charles River Laboratories
- ChemoCentryx
- Chi-Med
- Chiesi Farmaceutici
- Children's Hospital Boston
- Chromocell
- CIMAB SA
- Cincinnati Children’s Hospital Medical Center
- Circassia
- Clearside Biomedical
- Cleveland BioLabs
- Cleveland Clinic
- Clover Biopharmaceuticals
- CNA Development
- Coalition for Epidemic Preparedness Innovations
- Cochlear
- Cocoon Biotech
- Codexis
- Cold Genesys
- Complement Pharma
- Compugen
- Conatus Pharmaceuticals
- Concortis Biosystems
- Context Therapeutics
- Convelo Therapeutics
- Convergence Pharmaceuticals
- COPAN
- COPD Foundation
- Copenhagen University Hospital
- Cordis
- Corvia Medical
- COUR Pharmaceutical
- Crescendo Biologics
- CRISPR Therapeutics
- Cryolife
- CrystalGenomics
- CSL
- CSL Behring
- CStone Pharmaceuticals
- CTX Technology
- CureVac
- Curis
- Cutanogen
- Cyclo Therapeutics
- CymaBay Therapeutics
- Cynata Therapeutics
- CytomX Therapeutics
- Cytoo
- CYTOVIA Therapeutics
- Daewoong Pharmaceutical
- Daiichi Sankyo
- Dainippon Sumitomo Pharma
- DanDrit Biotech
- Dare Bioscience
- Dauntless Pharmaceuticals
- Debiotech
- Decibel Therapeutics
- de Duve Institute
- Deinove
- Dementia Discovery Fund
- Denali Therapeutics
- DendroCyte
- Denovo Biopharma
- Department of Defense
- Department of Veterans Affairs
- Dermelix Biotherapeutics
- Dermira
- DermSpectra
- Dewpoint Therapeutics
- DiamiR
- Diaprost
- Dicerna Pharmaceuticals
- DigiPath Solutions
- Dimerix Biosciences
- Domain Therapeutics
- Dow AgroSciences
- Dragonfly Therapeutics
- DSM
- Duke University
- Durect
- Dynavax Technologies
- E&B Technologies
- Eagle Pharmaceuticals
- EastGate Biotech
- Easton Pharmaceuticals
- EDAP TMS
- Edico Genome
- Edison Nation Medical
- Editas Medicine
- Edwards Lifesciences
- eFFECTOR Therapeutics
- Eisai
- Eisai S.A.S
- Elektrofi
- Eleven Biotherapeutics
- Eli Lilly
- EmboMedics
- Emendo Biotherapeutics
- Emergent BioSolutions
- Emisphere
- Emory University
- Enable Injections
- Endo Pharmaceuticals
- Endospan
- eNeura Therapeutics
- enGene
- EnGeneIC
- Enigma Biomedical
- Enteris Biopharma
- Enterome Bioscience
- EnWave
- Enzyvant Science
- Eppin Pharma
- Ergomed
- ERS Genomics
- Establishment Labs
- eTheRNA immunotherapies
- Eticann S.A.S. Zomac
- Eureka Therapeutic
- European Organization for Research and Treatment of Cancer
- Evestra
- Evotec
- Evox Therapeutics
- Exelixis
- Exicure
- Exovita Biosciences
- ExScientia
- EyeMedics
- F-Star
- F-Star Alpha
- Facit
- Fagron
- FairJourney Biologics
- Fate Therapeutics
- Fauna Bio
- Ferring Pharmaceuticals
- Five Prime Therapeutics
- FKD Therapies
- FOB Synthesis
- Fondazione Telethon
- Food and Drug Administration (FDA)
- Foresee Pharmaceuticals
- FORMA Therapeutics
- Fox Chase Cancer Center
- Fscan
- Fujifilm
- Fujifilm medical systems
- FX Therapeutics
- G-treeBNT
- G2B Pharma
- G3 Pharmaceuticals
- Gadeta
- Galapagos
- Galaxy Biotech
- Galecto Biotech
- Galmed Pharmaceuticals
- GamaMabs Pharma
- Gamida Cell
- GammaDelta Therapeutics
- GE Healthcare
- GEn1E Lifesciences
- GenEdit
- Genentech
- GenePeeks
- Genesee BioMedical
- Genethon
- GeNeuro
- Genexine
- Genisphere
- Genmab
- GenomeSmart
- GenVec
- Genzyme
- Georgetown University
- Georgetown University Hospital
- George Washington University
- GeoVax
- German Cancer Research Center
- Geron
- Gilead Sciences
- GlaxoSmithKline
- GlaxoSmithKline Biologicals
- Glenmark Pharmaceuticals
- Glide
- Global Blood Therapeutics
- Globavir Biosciences
- Glycotope Biotechnology
- Glykos
- GOG Foundation
- Goldfinch Bio
- GrayBug
- Gritstone Oncology
- Grunenthal
- Gurnet Point Capital
- GW Pharmaceuticals
- H3 Biomedicine
- Hadasit Medical Research Services and Development
- Haga Teaching Hospital
- Haibo Biotechnology Institute
- Hancock Jaffe Laboratories
- Hanmi Pharmaceutical
- Hannover Medical School
- Harpoon Therapeutics
- Harvard Stem Cell Institute
- Harvard University
- HEC Pharm
- Heidelberg Pharma
- Helius Medical Technologies
- Helmholtz Zentrum Munchen
- HemispheRx Biopharma
- Henlius Biotech
- Henry Ford Health System
- HiFiBio
- HistoIndex
- Hoffmann La Roche
- Horizon Discovery
- Horizon Pharma plc
- Horus Pharma
- Hospices Civils de Lyon
- Hoth Therapeutics
- Humanetics
- Hummingbird Bioscience
- Hutchison MediPharma
- I-mab
- Icahn School of Medicine at Mount Sinai
- Iconic Therapeutics
- IDEAYA Biosciences
- Idera Pharmaceuticals
- Idorsia
- IFM Therapeutics
- IGNITE Immunotherapy
- IHI
- Iktos
- ILTOO Pharma
- Imaxio
- Imbrium Therapeutics
- Imcyse
- Immatics Biotechnologies
- Immucor
- Immune Design
- ImmuNext
- Immunic
- ImmunID Technologies
- ImmunoBiochem
- ImmunoCellular Therapeutics
- Immunocore
- ImmunoGen
- Immunomedics
- Immunomic
- Immunovia
- Immunscape
- Imperial Innovations
- IMV
- Inception 5
- Inception Sciences
- Incuron
- Incyte
- Indivior
- Infinity Pharmaceuticals
- Infuseon Therapeutics
- Inhibitor Therapeutics
- Inhibrx
- Innate Pharma
- Innovasource
- Innovate UK
- Innovation Pharmaceuticals
- Innovent Biologics
- Innovet
- Inovio Pharmaceuticals
- Inserm Transfert
- Insitro
- Insmed Inc
- InSphero
- Institute for Research in Immunology and Cancer – Commercialization of Research
- Institute of Bioengineering and Nanotechnology
- Institute of Cancer Research
- Institut Pasteur
- Intarcia Therapeutics
- Intec
- Intellia Therapeutics
- Intellikine
- International Stem Cell
- Intrexon
- iNtRON Biotechnology
- InxMed
- Ionis Pharmaceuticals
- IONTAS
- Iovance Biotherapeutics
- IOVaxis Therapeutics
- iProgen Biotech
- Ipsen
- Ironwood Pharmaceuticals
- ISA Pharmaceuticals
- iSense CGM
- ISIS Innovation
- Isogenica
- Isoprene Pharmaceuticals
- Italfarmaco
- iTeos Therapeutics
- ITM Isotopen Technologien
- Iveric Bio
- Janssen Biotech
- Janssen Pharmaceuticals
- Janssen Research & Development
- Jazz Pharmaceuticals
- JFE Engineering
- Jiangsu Alphamab
- Jiangsu Hengrui Medicine
- Johns Hopkins Medicine (JHM)
- Johns Hopkins University
- Johnson & Johnson
- Johnson & Johnson Innovation
- Joslin Diabetes Center
- Jounce Therapeutics
- Juno Therapeutics
- Junshi Biosciences
- Jupiter Orphan Therapeutics
- Juventas Therapeutics
- KAHR Medical
- KAI Research
- Kairos Therapeutics
- Kaiser Permanente
- Kaken Pharmaceutical
- Kallyope
- KalVista Pharmaceuticals
- Kanyos
- Karolinska Institute
- KDAc Therapeutics
- Keck School of Medicine of USC
- KemPharm
- KineMed
- Kineta
- Kiniksa Pharmaceuticals
- KinoPharma
- Kite Pharma
- Klaria
- Knopp Biosciences
- Kochoptik
- KSF Acquisition
- Kymab
- Kymera Therapeutics
- Kyn Therapeutics
- Kyowa Hakko Kirin
- La Jolla Pharmaceutical
- Lantheus Medical Imaging
- Lead Discovery Center
- Leap Therapeutics
- Lee Moffitt Cancer Center
- Leidos
- Leon-nanodrugs
- LEO Pharma
- Les Laboratoires Servier
- Lexicon Pharmaceuticals
- LFB Biotechnologies
- LG Life Sciences
- Lineage Cell Therapeutics
- Lipidor
- Lockheed Martin
- LogicBio Therapeutics
- Lonza
- Ludwig Institute for Cancer Research
- Lunenfeld-Tanenbaum Research Institute
- Lunit
- Lupin Limited
- Lupus Therapeutics
- Lycera
- Lynkogen
- Lysogene
- MabVax Therapeutics
- Machavert Pharmaceuticals
- Macrogenics
- Magenta Therapeutics
- Mallinckrodt Pharmaceuticals
- Mannin Research
- Massachusetts General Hospital
- Mauna Kea Technologies
- Maverick Therapeutics
- MaveriX Oncology
- Max-Planck
- Mayo Clinic
- MBI
- MD Anderson Cancer Center
- MDRM Group (Canada)
- MedGenesis Therapeutix
- Medgenics
- Medherant
- Medical Prognosis Institute
- Medical University South Carolina
- MediciNova
- Medidata Solutions
- Medifocus
- MediGene
- MedImmune
- MED Institute
- Medizone International
- MEI Pharma
- Memorial Sloan Kettering Cancer Center
- Merck and Co
- Merck KGaA
- Merck Serono
- Merck Sharpe & Dohme
- Mereo BioPharma
- Merus
- Mesoblast
- Mezzion Pharma
- Microbiotica
- Midatech
- Millipede
- MiNA Therapeutics
- MiniVax
- Minneapolis Medical Research Foundation
- Mirati Therapeutics
- Mitsubishi Tanabe Pharma
- Moderna Therapeutics
- Modern Mobility Aids
- Modulus Discovery
- Molecular Templates
- Monopar Therapeutics
- Monsanto
- Morphic Therapeutic
- MorphoSys
- Morphotek
- Mount Sinai Health System
- MultiCell Immunotherapeutics
- Mundipharma
- Murdoch Childrens Research Institute
- MyBiotics Pharma
- Mylan Laboratories
- Mymetics
- Myonexus Therapeutics
- Myovant Sciences
- Myriad Genetics
- Nanobeak
- Nanobiotix
- NanoString Technologies
- NanoViricides
- NantBioScience
- Nantes University
- NantPharma
- Nanyang Technological University
- Natera
- National Cancer Institute
- National Center for Tumor Diseases
- National Comprehensive Cancer Network (NCCN)
- National Eye Institute
- National Heart
- Lung and Blood Institute
- National Institute of Allergy and Infectious Diseases
- National Institute of Neurological Disorders and Stroke
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- National Institute on Drug Abuse (NIDA)
- National Institutes of Health
- National Institutes of Health Center for Regenerative Medicine
- Nationwide Children’s Hospital
- Navidea Biopharmaceuticals
- NBE Therapeutics
- NEC
- Nektar Therapeutics
- Nemucore Medical Innovations
- NeoImmuneTech
- Neomed Institute
- Neon Therapeutics
- Neovacs
- Nestle Health Science
- Netherlands Cancer Institute
- NeuMoDx Molecular
- Neurocrine Biosciences
- NeuroSigma
- NeuroVive Pharmaceutical
- Nevada Center For Behavioral Health
- New England Research Institutes
- Newlink Genetics
- New York State
- NextCure
- Nextera
- NGM Biopharmaceuticals
- Nicox
- Nihon Medi-Physics
- Nimbus Therapeutics
- Nodality
- Noile-Immune Biotech
- Nordic Nanovector
- Nordion
- NorthBay Healthcare
- Northern Biologics
- Northwestern University
- NovaMedica
- Novartis
- Novo Nordisk
- Novozymes Biopharma
- Noxxon Pharma
- Nrgene
- Nuevolution
- Nuformix
- NuGene International
- Numab
- Nuo Therapeutics
- Nurix
- Obsidian Therapeutics
- Ocular Therapeutics
- Ohr Pharmaceuticals
- OKYO Pharma
- Omeros
- Oncodesign
- OncoImmune
- Oncology Venture
- OncoSec Medical
- Oncosynergy
- OnDosis
- One Way Liver Genomics (OWL)
- OnKure
- Ono Pharmaceutical
- Ophthotech
- OPKO Health
- OptiBiotix
- Oraxion Therapeutics
- Orbis
- Orbit Biomedical
- Orca Pharmaceuticals
- Orchard Therapeutics
- Oregon Health Sciences University
- ORFLO Technologies
- Organic Vaccines
- Organogenesis
- Orion
- Orthofix
- Ortoma
- OSE Immunotherapeutics
- Ossianix
- Oswaldo Cruz Foundation (Fiocruz)
- Ovensa
- Oxford BioMedica
- Oxford BioTherapeutics
- Oxford Genetics
- Oxis Biotech
- Oxurion
- Pacific Edge Biotechnology
- Pairwise Plants
- Panion
- Panther Biotechnology
- Parion Sciences
- Pascal Biosciences
- Passage Bio
- PDC*line Pharma
- PEAR Therapeutics
- PellePharm
- Pepsico
- PeptiDream
- PeptiMimesis
- PerkinElmer
- Pfenex
- Pfizer
- Pharmacyclics
- PharmaIN
- PharmaJet
- Pharmatech
- Pharming Group
- Pherin Pharmaceuticals
- Philogen
- Phio Pharmaceuticals
- PhoreMost
- Phosplatin Therapeutics
- Phylogica
- PhysIQ
- PhytoTech Medical
- Pieris
- Pierre Fabre
- Piqur Therapeutics
- Plant Bioscience Limited
- Potenza Therapeutics
- Precision BioSciences
- Premune
- Prevail Therapeutics
- PreveCeutical Medical
- Prime Therapeutics
- ProBioGen
- Pronutria
- Protagonist Therapeutics
- Protein Sciences
- Proteomics International
- Prothelia
- Prothena Biosciences
- pSivida
- Pulmatrix
- Pulmonox
- Purdue Pharma
- Puregraft
- Puridify
- PvP Biologics
- Q BioMed
- Qiagen
- QT Vascular
- Quad Technologies
- Quark Venture
- Quartet Medicine
- Quebec Consortium for Drug Discovery
- Queensland Institute of Medical Research (QIMR)
- Quotient Clinical
- Rafael Pharmaceuticals
- Rani Therapeutics
- Rappaport Research Institute
- Raptor Pharmaceutical
- Recursion Pharmaceuticals
- RedHill Biopharma
- Regeneron Pharmaceuticals
- Regenerx
- Regenesys
- Regenxbio
- Regulus Therapeutics
- RenalytixAI
- Reproductive Medicine Associates of New York
- Resolution Bioscience
- Respicardia
- RESprotect
- Resverlogix
- Retrophin
- rEVO Biologics
- Revolution Medicines
- Rexahn Pharmaceuticals
- Rheos Medicines
- Ribometrix
- Robert H. Lurie Comprehensive Cancer Center
- Roche
- Rocket Pharmaceuticals
- Rockwell Medical
- Rodin Therapeutics
- Rohto Pharmaceutical
- Roivant Sciences
- Romer Labs
- Rosetta Genomics
- Roswell Park Cancer Institute
- Rugen Therapeutics
- Rumpus Therapeutics
- RXi Pharmaceuticals
- SAB Biotherapeutics
- Salix Pharmaceuticals
- Salud Digna
- SAMIL Pharm
- Samsung Bioepis
- Samyang Biopharmaceuticals
- Sandoz
- Sangamo BioSciences
- San Martino Hospital
- Sanofi
- Sanofi-Aventis
- Sanofi-Pasteur
- San Raffaele Scientific Institute
- San Raffaele Telethon Institute for Gene Therapy
- Santaris Pharma
- Santen Pharmaceutical
- Santhera Pharmaceuticals
- Sarepta Therapeutics
- Scholar Rock
- Schrodinger
- ScreenCell
- Scripps Research Institute
- Scripps Translational Science Institute
- Seattle Genetics
- Selecta Biosciences
- SemaThera
- Senexta
- Senju Pharmaceutical
- Senomyx
- Sensorion
- Sentinel Oncology
- Sequenom
- Seres Therapeutics
- Serum Institute of India
- Seven and Eight Biopharmaceuticals
- Sevion Therapeutics
- Shattuck Labs
- Shenzhen Chipscreen Biosciences
- Shenzhen Hepalink Pharmaceutical
- Shin Nippon Biomedical Laboratories
- Shionogi
- Shire Pharmaceuticals
- Siamab Therapeutics
- Siemens
- Signet International
- Signet Medical Solutions
- Singapore Immunology Network
- Singapore Institute of Advanced Medicine
- SiO2 Medical Products
- Sirenas
- Sirona Genomics
- SkyePharma
- Skyhawk Therapeutics
- Small Business Innovation Research
- Societatea Nationala Nuclearelectrica
- SolaranRx
- Sorin Group
- Sorrento Therapeutics
- Sosei
- SOTIO
- Spark Therapeutics
- Specialised Therapeutics
- Spectral Medical
- Spero Therapeutics
- Spherix
- Sphingotec
- SpineThera
- Spring Bank Pharmaceuticals
- SpringWorks Therapeutics
- Squalan Natural Health
- St. Jude Children's Research Hospital
- Stahl
- Stallargenes
- Stanford University
- Starpharma
- Staten Biotechnology
- STC.UNM
- Stealth Therapeutics
- St George Street Capital
- Strategic Science and Technologies
- StrideBio
- Sucampo Pharmaceuticals
- Sumitovant Biopharma
- Summit Therapeutics
- SurePure
- Surface Oncology
- Sutro Biopharma
- Suzhou NeuPharma
- Swedish Orphan Biovitrum
- Symphogen
- Synaffix
- Syndax Pharmaceuticals
- Synlogic
- Synthetic Genomics
- Syros Pharmaceuticals
- Taiho
- Taiwan Liposome Company
- Takeda Pharmaceutical
- Takeda Ventures
- Talix Therapeutics
- Tamarack Biotics
- Tango Therapeutics
- TapImmune
- Targacept
- Targovax
- Taxus Cardium Pharmaceuticals
- Techcomp
- Technology University Dresden
- Teijin
- Tekmira Pharmaceuticals
- Tel Aviv University
- Teleflex
- Telix Pharmaceuticals
- Temple University
- TeneoBio
- TeneoOne
- Terumo BCT
- Tesaro
- Tetra Bio-Pharma
- Tetra Discovery Partners
- Tetragenetics
- Teva Pharmaceutical Industries
- The Parker Institute For Cancer Immunotherapy
- Theragnostics
- Therapeia
- Therapix Bio
- Theravance
- Thomas Jefferson University
- TiGenix
- Titan Pharmaceuticals
- Tiziana Life Sciences
- Tizona Therapeutics
- T Med
- Todos Medical
- Torque Therapeutics
- TRACON Pharmaceuticals
- TransBio
- Transgene
- Transgenomic
- Transition Therapeutics
- Transparency Life Sciences
- Trefoil Therapeutics
- Triphase Accelerator
- TriReme Medical
- Trizell
- True North Laboratory
- Tsinghua University
- Tubulis
- Tufts Medical Center
- Tufts University
- Turnstone Biologics
- TxCell
- Tyme Technologies
- Ubiquigent
- UbiVac
- Ultragenyx Pharmaceuticals
- UMN Pharma
- Unilife
- UniQuest
- Universite catholique de Louvain
- Universite Laval
- University College London
- University Medical Center Groningen
- University Medical Center Hamburg-Eppendorf
- University of Bonn
- University of California Los Angeles
- University of California San Francisco
- University of Chicago
- University of Cincinnati
- University of Colorado
- University of Connecticut
- University of Florida
- University of Florida Research Foundation
- University of Guelph
- University of Illinois at Chicago
- University of Kentucky
- University of Leipzig
- University of Maryland Baltimore
- University of Maryland Ventures
- University of Massachusetts
- University of Massachusetts
- Amherst
- University of Massachusetts Medical School
- University of Miami
- University of Minnesota
- University of Montreal
- University of Nevada
- University of New Mexico
- University of Oxford
- University of Pennsylvania
- University of Pittsburgh
- University of Rochester
- University of Sydney
- University of Texas Southwestern Medical Center
- University of Toronto
- University of Washington
- University of Wisconsin
- UroGen Pharma
- Urovant Sciences
- US Army
- US Army Medical Research Institute of Chemical Defense
- US Army Medical Research Institute of Infectious Diseases
- US Department of Veteran Affairs
- US Veterans Administration
- Vaccinex
- Valens GroWorks
- Valneva
- Vantage Health
- Vasomune Therapeutics
- Vaxart
- Vaximm
- VDM Biochemicals
- Vect-Horus
- Vectura
- Vedanta Biosciences
- Velo Bio
- Ventana Medical Systems
- VentiRx Pharmaceuticals
- Verastem
- Versant Ventures
- Vertex Pharmaceuticals
- ViaCyte
- Vifor-Fresenius Medical Care Renal Pharma Ltd
- Vifor Pharma
- Vinnova
- Virax
- Vir Biotechnology
- Viroclinics Biosciences
- VistaGen Therapeutics
- Visterra
- Vitae Pharmaceuticals
- Vitaeris
- VitalConnect
- Vital Therapies
- Vitrisa Therapeutics
- Vivaldi Biosciences
- Vivet Therapeutics
- Vivione Biosciences
- Vivior
- Vivoryon Therapeutics
- Vivus
- Volpara Solutions
- Voluntis
- Voyager Therapeutics
- Vyriad
- Washington University in St Louis
- WAVE Life Sciences
- Weill Cornell Medical College
- Western Oncolytics
- WinterLight Labs
- Wistar Institute
- Women & Infants Hospital of Rhode Island
- Worldwide Clinical Trials
- X-chem
- Xencor
- Xenon Pharmaceuticals
- XERIS Pharmaceuticals
- Xoma
- Yale University
- Yeda Research and Development Company
- Yissum Research Development
- Yonsei University Severance Hospital
- YouHealth Eyetech
- ZAI Laboratory
- ZappRx
- Zealand Pharma
- Ziopharm Oncology
- Zoetis
- Zomedica
- Zymeworks
Methodology
- The publisher reports provide insight into the trends and terms of partnering deals in the global life sciences sector.
- The publisher reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.
- The publisher analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.
- The publisher reports source deal data from our proprietary deals and alliances database. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal.
- The data in the deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.
The publisher provides comprehensive coverage of the following partnering or deal types:
- Asset purchase
- Assignment
- Co-development
- Co-market
- Co-promotion
- Collaborative R&D
- Contract service
- CRADA
- Cross-licensing
- Development
- Distribution
- Equity purchase
- Evaluation
- Grant
- Joint venture
- Licensing
- Loan
- Manufacturing
- Marketing
- Option
- Promotion
- Research
- Royalty financing
- Settlement
- Spin out
- Sub license
- Supply
- Termination
- Warrant
Every deal record is fully categorized and includes the following data, where available:
- Industry sector
- Therapy areas
- Technology type
- Deal components
- Financial terms
- Stage of development
- Exclusivity
- Asset type
- Geographic focus
- Excluded geography
- Company press release
- SEC filing data including contract document
All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.
LOADING...
